AB Large Cap Value A ABVAX
Set alert
22.23 USD 0.00 0.00%
At close · Nov 2
Day range unavailable
17.90 52-week range 22.41
- YTD
- +23.16%
- 1 year
- +15.96%
- Open
- —
- Prev close
- 22.23
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 19.38
- 200-d avg
- 18.43
2Y chart
Events in this range
- Dec 11, 2025Dividend: 1.7372
Signals (70)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 7, 2026 | 3 weeks ago |
| SMA: Bullish | Sep 11, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| RSI: Overbought | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Overbought | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 9, 2026 | 3 months ago |
| RSI: Overbought | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 10, 2026 | 4 months ago |
| RSI: Overbought | Jun 4, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 2, 2026 | 5 months ago |
| MACD: Sell Signal | May 29, 2026 | 5 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| MACD: Sell Signal | May 13, 2026 | 5 months ago |
| RSI: Overbought | May 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
Newest 20 of 70.
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 19.38
- 200-day average
- 18.43
About AB Large Cap Value A
The fund invests in a diversified portfolio of equity securities of large capitalization companies that the Adviser believes are undervalued. The fund invests in companies that are determined by the Adviser to be undervalued using the fundamental value approach of the Adviser. Under normal circumstances, the fund invests at least 80% of its net assets, including any borrowings for investment purposes, in equity securities of large capitalization companies.
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on ABVAX — it syncs with the Stock Master app.
